Literature DB >> 477710

Blood level of cimetidine in relation to age.

A Redolfi, E Borgogelli, E Lodola.   

Abstract

The blood level versus time curve for unchanged cimetidine after a 200 mg oral dose has been determined in 20 apparently healthy subjects, ranging from 22 to 84 years of age. A significant relationship between the area under the curve (AUC) and age was found (r = 0.81; P less than 0.001). The peak concentrations of cimetidine were significantly inversely related to body weight (r = -0.71; P less than 0.001). The age-related increase in bioavailability of oral cimetidine, as measured by AUC, was probably due to decreased total clearance of the drug, which resulted from the opposed changes (by themselves not significant) of distribution volume towards a decrease and of half-life towards an increase with age. Reduction in the standard oral dose of cimetidine by one third to one half should be feasible in the elderly without loss of efficacy, and it may be advisable in order to obviate extreme individual responses that may occur in this population.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477710     DOI: 10.1007/bf00618514

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.

Authors:  J W Rowe; R Andres; J D Tobin; A H Norris; N W Shock
Journal:  J Gerontol       Date:  1976-03

2.  Absorption and disposition of chlordiazepoxide in young and elderly male volunteers.

Authors:  R I Shader; D J Greenblatt; J S Harmatz; K Franke; J Koch-Weser
Journal:  J Clin Pharmacol       Date:  1977 Nov-Dec       Impact factor: 3.126

3.  Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.

Authors:  W L Burland; W A Duncan; T Hesselbo; J G Mills; P C Sharpe; S J Haggie; J H Wyllie
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

Review 4.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

5.  Functional defects in the aging kidney.

Authors:  S A Friedman; A E Raizner; H Rosen; N A Solomon; W Sy
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

6.  Bioavailability of cimetidine in man.

Authors:  S S Walkenstein; J W Dubb; W C Randolph; W J Westlake; R M Stote; A P Intoccia
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

7.  Cimetidine and mental confusion.

Authors:  J C Delaney; M Ravey
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

8.  Cimetidine and mental confusion.

Authors:  M A McMillen; D Ambis; J H Siegel
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

9.  Effects of renal failure on blood levels of cimetidine.

Authors:  K W Ma; D C Brown; D S Masler; S E Silvis
Journal:  Gastroenterology       Date:  1978-02       Impact factor: 22.682

Review 10.  Pharmacokinetics in the elderly.

Authors:  J Crooks; K O'Malley; I H Stevenson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more
  18 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Prescription monitoring of drug dosages in the county of Jämtland and Sweden as a whole in 1976, 1982 and 1985.

Authors:  A Wessling; G Boëthius; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.

Authors:  N Inotsume; M Nishimura; S Fujiyama; K Sagara; T Sato; Y Imai; H Matsui; M Nakano
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Increased bioavailability of cimetidine with age?

Authors:  A Somogyi; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

6.  Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.

Authors:  Felix Stader; Hannah Kinvig; Melissa A Penny; Manuel Battegay; Marco Siccardi; Catia Marzolini
Journal:  Clin Pharmacokinet       Date:  2020-03       Impact factor: 6.447

7.  Drugs in the elderly.

Authors:  M M Reidenberg
Journal:  Bull N Y Acad Med       Date:  1980-10

8.  Human placental transport of cimetidine.

Authors:  S Schenker; J Dicke; R F Johnson; L L Mor; G I Henderson
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

9.  Cimetidine dosage regimen for patients with renal failure and for geriatric patients.

Authors:  W A Ritschel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.